Aptiom

Chemical Nameeslicarbazepine acetate
Dosage FormTablet (oral; 200 mg, 400 mg, 600 mg, 800 mg)
Drug ClassAnticonvulsants
SystemNervous
CompanySunovion Pharmaceuticals
Approval Year2013

Indication

  • Indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Last updated on 6/22/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Aptiom (eslicarbazepine acetate) Prescribing Information.2019Sunovion Pharmaceuticals Inc., Marlborough, MA